National Institute on Drug Abuse (NIDA) is a government-backed investor. Among the 9 companies in the known portfolio are Omeros, Myosin Therapeutics, Sparian Biosciences, Akyso, Anebulo Pharmaceuticals and Berkshire Biomedical.
Is National Institute on Drug Abuse (NIDA) a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- Addiction ResearchBiotechDiagnosticsDrug DiscoveryMental HealthPharmaSubstance Use
National Institute on Drug Abuse (NIDA) portfolio companies (9)
- Omeros
- Myosin Therapeutics
- Sparian Biosciences
- Akyso
- Anebulo Pharmaceuticals
- Berkshire Biomedical
- Enalare Therapeutics
- Ensysce Biosciences
- ReacX Pharmaceuticals
Co-investors
Funds that share portfolio companies with National Institute on Drug Abuse (NIDA).
Similar funds
Showing 20 of 100
About National Institute on Drug Abuse (NIDA)
The firm's listing covers sector Healthcare, and focus areas Addiction Research, Biotech, Diagnostics and Drug Discovery; known deals cluster at Pre-Seed and Seed.
Across the known portfolio, 6 co-investors appear alongside National Institute on Drug Abuse (NIDA), including Polar Asset Management Partners, The National Institutes of Health and Uk Innovation & Science Seed Fund.
Frequently asked questions
What is National Institute on Drug Abuse (NIDA)?
National Institute on Drug Abuse (NIDA) is a government-backed investor with a known portfolio of 9 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does National Institute on Drug Abuse (NIDA) invest in?
Listed sectors include Healthcare; listed focus areas include Addiction Research, Biotech, Diagnostics and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
What stage does National Institute on Drug Abuse (NIDA) invest at?
The known deals of National Institute on Drug Abuse (NIDA) include Pre-Seed and Seed rounds. Check that against your own round before reaching out: stage mismatch is the most common reason a well matched sector still goes nowhere.
How do I contact National Institute on Drug Abuse (NIDA)?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal